APA-ийн эшлэл(7 дахь хэвлэлт)

Eaton, C., Wells, J., Holen, I., Croucher, P., & Hamdy, F. (2004). Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Чикаго-гийн эшлэл (17 дахь хэвлэлт)

Eaton, C., J. Wells, I. Holen, P. Croucher, ба F. Hamdy. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.

MLA -ийн эшлэл (9 дэх хэвлэлт)

Eaton, C., et al. Serum Osteoprotegerin (OPG) Levels Are Associated with Disease Progression and Response to Androgen Ablation in Patients with Prostate Cancer. 2004.